Home > Boards > US OTC > Medical - Drugs > Mosaic Nutraceuticals (MCNJ)

MAY 2004

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Churak Member Profile
Member Level 
Followed By 375
Posts 105,977
Boards Moderated 12
Alias Born 05/18/02
160x600 placeholder
Churak Member Level  Wednesday, 11/17/04 07:28:36 PM
Re: Major_Bankz post# 1
Post # of 15 
MAY 2004
Epublishedbooks.com Acquires 100% Of Westchester Group Inc. And Changes Name To Mosaic Nutriceuticals Corp.

For Immediate Release

LAS VEGAS, Nevada/EWORLDWIRE/May 27, 2004 --- ePublishedBooks.COM (Cusip #29438P 10 5)(Pinksheets: EPBL) today announced that it has acquired 100% of issued and outstanding shares of Westchester Group Inc.

Westchester Group owns development and marketing rights for various nutraceutical "chew" products. The company is in the process of bringing this new line of health products to market.

EPBL is issuing 32,062,500 shares of $.001 par value common voting stock for each of the issued and outstanding shares of Westchester. Shares thus converted shall be deemed for all corporate purposes (other than the payment of dividends) to evidence the ownership of the number of fully paid, non-assessable shares of $.001 par value common voting stock of the surviving corporation into which shares of Westchester common stock shall have been so converted.

Pre-merger EPBL effected a three to one stock split resulting in 5,949,300 common shares of EPBL issued and outstanding.

In addition, EPBL agreed to issue a total of 11,000,000 shares of restricted stock to Westchester directors Charles Townsend and John Castleberry as part of the merger. Post-merger there were 49,011,800 shares of $.001 par value common stock of EPBL, the Surviving Corporation, issued and outstanding.

EPBL will immediately apply for a new trading symbol from the NASD to reflect its name change to Mosaic Nutriceuticals Corp. and to make application for a new CUSIP number with Standard & Poors.

Statements in this release are made pursuant to the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties including, without limitation, continued acceptance of the Company's services, increased levels of competition for the Company and dependence on the performance of the Management of the Company.

Charles Townsend
Mosaic Nutriceuticals Corp.
PHONE. 469-556-2986
Fax: 214-447-9235
Email: townsend@airmail.net


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences